CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth
about
CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppressionImmune escape mechanisms in colorectal cancer pathogenesis and liver metastasisGlioblastoma: a pathogenic crosstalk between tumor cells and pericytesA2aR antagonists: Next generation checkpoint blockade for cancer immunotherapyAdenosine A2A receptors intrinsically regulate CD8+ T cells in the tumor microenvironmentMicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73.Low expression of CD39 and CD73 genes in centenarians compared with octogenarians.CD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients.Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice.Ecto-5'-nucleotidase expression is associated with the progression of renal cell carcinoma.Loss of CD73-mediated actin polymerization promotes endometrial tumor progression.Anti-CD73 in cancer immunotherapy: awakening new opportunities.nab-Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors.Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.Cellular and molecular mechanisms in cancer immune escape: a comprehensive review.Extracellular adenosine metabolism in immune cells in melanoma.Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer.Induced regulatory T cells in inhibitory microenvironments created by cancer.Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression.Inosine strongly enhances proliferation of human C32 melanoma cells through PLC-PKC-MEK1/2-ERK1/2 and PI3K pathways.Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.Targeting A2 adenosine receptors in cancer.Targeting adenosine in cancer immunotherapy: a review of recent progress.Melatonin receptor deficiency decreases and temporally shifts ecto-5'-nucleotidase mRNA levels in mouse prosencephalon.The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma.Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial.Evaluation of WO2017098421: GSK's benzothiazine compounds as CD73 inhibitor filings.Hypoxia-Driven Adenosine Accumulation: A Crucial Microenvironmental Factor Promoting Tumor Progression.
P2860
Q26801436-B5CB1602-FF44-4506-A274-9631C65162BBQ27002388-C1692DAA-3885-4213-B37F-55176E931703Q27320839-AA94B3D7-E31A-4F06-8A4E-7211B0993D7EQ28087576-C10C27F3-D072-41CB-BCD4-184F8E9878DCQ28250207-6EB116D1-9FA3-48B2-853D-131473719E75Q33630440-5B9886BF-076D-4936-8119-73648720A694Q33705870-3BA6F731-AC94-4325-8F74-183A136993A8Q34473048-FE1790B1-5287-4A31-8B47-97254B36B9A4Q34539323-D461EC8F-C24E-4734-843E-9222ED069093Q34695338-785097CC-3031-4375-AB4F-A484AFF40D93Q35758898-737531FA-D78B-4411-A7B1-E63457AB0D84Q36430733-B3DD3851-F705-4037-9942-FD9514F28B2EQ36709157-F1BD95E7-C5F5-4755-BFED-9564EE6C3FD1Q37536367-F15D66E8-22C7-41DF-BF91-67CD588D4D19Q37702792-534962D7-2C22-4840-A287-04A793BBA980Q38170150-E003EE67-EFF9-4454-B137-5A5756570D09Q38206399-8F6870DA-B456-4346-A717-5EF54635C4FEQ38209586-240CE3AE-C4B7-44A2-82B9-B5CB587D914CQ38220701-F6A3B379-B07A-4612-A96D-369B18E0A117Q38936385-ADCE690D-52BD-43B8-8B82-F0D06F471006Q38987177-826F284E-EE33-4156-8A8C-BE41B815444DQ39002543-B02AC624-E44E-45F9-B726-C226F571A395Q39125149-165E34AD-C2DD-48D2-983D-C1384C67624AQ39235260-CD9C5EA4-5056-4004-8A61-91201AEE42C5Q39967207-DB78FFFD-C931-4C0B-AF70-798DF5D4EEFAQ41441746-FB492F2A-B088-42D8-B48B-A47BA4BABF2CQ42094877-D763DF0C-C141-4500-8A0B-8F3E4DDD8424Q46026307-932114A6-7D02-4A90-B7AC-8EA18A8F47CAQ47395423-1D2D8CD1-243F-48DD-BD8B-568297E54856Q49791703-B8E3E42B-2066-4DDF-BA5A-62CB11ADD9CCQ51554659-760C823B-555F-43AC-B82E-A00DC7D51952
P2860
CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
CD73-generated adenosine: orch ...... rplay to promote cancer growth
@ast
CD73-generated adenosine: orch ...... rplay to promote cancer growth
@en
CD73-generated adenosine: orch ...... rplay to promote cancer growth
@nl
type
label
CD73-generated adenosine: orch ...... rplay to promote cancer growth
@ast
CD73-generated adenosine: orch ...... rplay to promote cancer growth
@en
CD73-generated adenosine: orch ...... rplay to promote cancer growth
@nl
prefLabel
CD73-generated adenosine: orch ...... rplay to promote cancer growth
@ast
CD73-generated adenosine: orch ...... rplay to promote cancer growth
@en
CD73-generated adenosine: orch ...... rplay to promote cancer growth
@nl
P2093
P2860
P921
P356
P1476
CD73-generated adenosine: orch ...... rplay to promote cancer growth
@en
P2093
Bertrand Allard
John Stagg
Martin Turcotte
P2860
P304
P356
10.1155/2012/485156
P407
P577
2012-01-01T00:00:00Z
2012-10-16T00:00:00Z